The principle of an ultrasonic nebulizer is based on the vibrations of a pi
ezoelectric crystal driven by an alternating electrical field. These period
ic vibrations are characterized by their frequency, their amplitude, and th
eir intensity, which corresponds to the energy transmitted per surface unit
. When the vibration intensity is sufficient, cavitation occurs, and drople
ts are generated. Ventilation enables airflow to cross the nebulizer and to
expel the aerosol droplets. For a given nebulizer, the vibration frequency
of the piezoelectric crystal is fixed, often in the range 1-2.5 MHz. In mo
st cases, an adjustment in vibration intensity is possible by modifying vib
ration amplitude. The ventilation level is adjustable. The vibrations may b
e transmitted through a coupling liquid-commonly water to a nebulizer cup c
ontaining the solution to be aerosolized. In this work, we studied the infl
uence of the technological parameters of ultrasonic nebulization on nebuliz
ation quality. Our study was carried out with a 9% sodium chloride solution
and a 2% protein solution (alpha1 protease inhibitor). Three different ult
rasonic nebulizers were used. An increase in vibration frequency decreased
the size of droplets emitted. The coupling liquid absorbed the energy produ
ced by the ultrasonic vibrations and canceled out any heating of the soluti
on, which is particularly interesting for thermosensitive drugs. An increas
e in vibration intensity did not modify the size of droplets emitted, but d
ecreased nebulization time and raised the quantity of protein nebulized, th
us improving performance. On the other hand, an increase in ventilation inc
reased the size of emitted droplets and decreased nebulization time and the
quantity of protein nebulized because more drug was lost on the walls of t
he nebulizer. High intensity associated with low ventilation favors drug de
livery deep into the lungs.